News

You can improve your skin texture through a combination of natural self-care methods, skincare products, and treatment ...
The U.S. Food and Drug Administration has approved Abeona Therapeutics' Zevaskyn (prademagene zamikeracel) for patients with ...
The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday. The ...
Medically reviewed by Casey Gallagher, MD Atopic dermatitis (AD) is a chronic (long-term) skin condition that causes itchy, ...
Researchers at the University Health Network (UHN) and the University of Toronto have developed a skin-based test that can detect signature features of progressive supranuclear palsy (PSP), a rare ...
Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal ...
People with xeroderma pigmentosum can severely burn within minutes of being in the sun and are thousands of times more likely ...